|
Atomistry » Chlorine » PDB 5sdd-5sil » 5sfg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 5sdd-5sil » 5sfg » |
Chlorine in PDB 5sfg: Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-CarboxamideEnzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide:
3.1.4.17; Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide, PDB code: 5sfg
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5sfg:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
(pdb code 5sfg). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide, PDB code: 5sfg: Jump to Chlorine binding site number: 1; 2; 3; 4; Chlorine binding site 1 out of 4 in 5sfgGo back to![]() ![]()
Chlorine binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
![]() Mono view ![]() Stereo pair view
Chlorine binding site 2 out of 4 in 5sfgGo back to![]() ![]()
Chlorine binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
![]() Mono view ![]() Stereo pair view
Chlorine binding site 3 out of 4 in 5sfgGo back to![]() ![]()
Chlorine binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
![]() Mono view ![]() Stereo pair view
Chlorine binding site 4 out of 4 in 5sfgGo back to![]() ![]()
Chlorine binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with N- [(3R)-1-(5-Chloropyridin-2-Yl)Pyrrolidin-3-Yl]-6-Cyclopropyl-3- (Pyrimidin-5-Ylamino)Pyridine-2-Carboxamide
![]() Mono view ![]() Stereo pair view
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
Page generated: Fri Jul 26 16:47:49 2024
ISSN: ESSN 1573-4951 PubMed: 36153472 DOI: 10.1007/S10822-022-00478-X |
Last articlesZn in 9J0NZn in 9J0O Zn in 9J0P Zn in 9FJX Zn in 9EKB Zn in 9C0F Zn in 9CAH Zn in 9CH0 Zn in 9CH3 Zn in 9CH1 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |